Lumimpa, Kristine S.

HRN: 04-47-41  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/10/2023
CEFUROXIME 500MG (TAB)
02/10/2023
02/17/2023
ORAL
500
BID
Rmle
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: